Pierre Sujobert Selected Research

Pierre Sujobert Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 02/2013
14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 08/2005
9	Lymphoma (Lymphomas) 01/2022 - 02/2013
4	VEXAS syndrome 01/2022 - 10/2021
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 05/2013
3	Leukemia 12/2021 - 12/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 01/2016
2	Acute Promyelocytic Leukemia 01/2022 - 01/2017
2	B-Cell Lymphoma (Lymphoma, B Cell) 08/2021 - 01/2016
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2021 - 08/2013
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2021
1	Hematologic Neoplasms (Hematological Malignancy) 02/2021
1	Residual Neoplasm 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2019
1	T-Cell Lymphoma (Lymphoma, T Cell) 11/2018
1	Sarcoma (Soft Tissue Sarcoma) 02/2018
1	Suppuration 02/2018
1	Infections 02/2018
1	Disease Progression 01/2018
1	Metabolic Diseases (Metabolic Disease) 01/2018
1	Lymphocytosis 01/2017
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2016
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 08/2013
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 05/2013
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2013
1	Mesenteric Ischemia 08/2007

Drug/Important Bio-Agent (IBA)

4	Chimeric Antigen ReceptorsIBA 01/2022 - 11/2020
4	Mechanistic Target of Rapamycin Complex 1IBA 07/2016 - 01/2008
3	Biological ProductsIBA 01/2022 - 01/2021
3	GSK621IBA 01/2022 - 06/2015
3	Phosphotransferases (Kinase)IBA 04/2020 - 08/2013
2	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 08/2013
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 08/2013
2	tisagenlecleucelIBA 01/2021 - 11/2020
2	axicabtagene ciloleucelIBA 01/2021 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2007
2	Proteins (Proteins, Gene)FDA Link 04/2020 - 08/2013
2	Tyrosine Kinase InhibitorsIBA 09/2019 - 09/2015
2	Pharmaceutical PreparationsIBA 02/2018 - 01/2016
2	Rituximab (Mabthera)FDA Link 01/2018 - 06/2017
2	AMP-Activated Protein KinasesIBA 01/2018 - 07/2016
2	Protein Isoforms (Isoforms)IBA 01/2016 - 08/2005
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2016 - 01/2008
1	Chlorambucil (Leukeran)FDA Link 01/2022
1	ruxolitinibIBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Codon (Codons)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	EnzymesIBA 01/2022
1	AA amyloidosisIBA 12/2021
1	CPX-351IBA 12/2021
1	Lenalidomide (CC 5013)FDA Link 10/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2021
1	Circulating Tumor DNAIBA 06/2021
1	Biological FactorsIBA 01/2021
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2020
1	Antimitotic AgentsIBA 01/2020
1	Vitamin D FDA LinkGeneric 01/2020
1	blinatumomabIBA 10/2019
1	Azacitidine (5 Azacytidine)FDA Link 11/2018
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 02/2018
1	NucleotidesIBA 01/2018
1	ParaffinIBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	Co-Repressor ProteinsIBA 10/2017
1	Peroxidase (Myeloperoxidase)IBA 01/2017
1	ibrutinibIBA 01/2017
1	idelalisibIBA 01/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2016
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2016
1	Glutamine (L-Glutamine)FDA Link 09/2015
1	fms-Like Tyrosine Kinase 3IBA 09/2015
1	proto-oncogene proteins pimIBA 09/2015
1	Tyrosine (L-Tyrosine)FDA Link 08/2013
1	AntibodiesIBA 05/2013
1	StathminIBA 05/2013
1	CyclinsIBA 02/2013
1	Cyclin D1IBA 02/2013
1	TOR Serine-Threonine KinasesIBA 01/2008
1	Insulin (Novolin)FDA Link 01/2008
1	C-Reactive ProteinIBA 08/2007
1	SteroidsIBA 08/2007
1	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2005

Therapy/Procedure

8	Therapeutics 01/2022 - 08/2007
4	Drug Therapy (Chemotherapy) 01/2021 - 04/2019
2	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2021
1	Homologous Transplantation 10/2021
1	Transjugular Intrahepatic Portasystemic Shunt 06/2021
1	Stem Cell Transplantation 01/2021
1	Aftercare (After-Treatment) 01/2018
1	Induction Chemotherapy 01/2018
1	Immunotherapy 10/2017
1	Precision Medicine 10/2017